Placulumab
Monoclonal antibody | |
---|---|
Type | ? |
Source | Human |
Target | TNF |
Clinical data | |
ATC code | none |
Identifiers | |
CAS Number | 945781-29-3 |
ChemSpider | none |
Chemical and physical data | |
Formula | C3404H5262N902O1036S22 |
Molar mass | 78.7 kg/mol |
Placulumab is a human monoclonal antibody designed for the treatment of inflammatory diseases.[1]
This drug was developed by Teva Pharmaceutical Industries, Inc. As of 2012, development of placulumab has been discontinued.
References
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Placulumab, American Medical Association.
This article is issued from Wikipedia - version of the 2/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.